A Bright Future for PGS & PGD with Simon Fishel | Illumina Video

11 November 2014

Innovative Illumina reproductive and genetic solutions are creating a bright future in PGS. The highly-accurate VeriSeqTM PGS Kit empowers clinicians with accurate chromosomal insights into the health of the embryo to optimize IVF success. http://www.illumina.com/clinical/reproductive-genetic-health.ilmn

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.